Norges Bank Invests $3.39 Million in Alignment Healthcare, Inc. (NASDAQ:ALHC)

Norges Bank acquired a new stake in Alignment Healthcare, Inc. (NASDAQ:ALHCFree Report) in the 4th quarter, HoldingsChannel.com reports. The institutional investor acquired 300,957 shares of the company’s stock, valued at approximately $3,386,000.

Other large investors also recently bought and sold shares of the company. Caisse Des Depots ET Consignations bought a new stake in shares of Alignment Healthcare in the 4th quarter valued at approximately $2,243,000. Vanguard Group Inc. raised its position in shares of Alignment Healthcare by 1.7% during the 4th quarter. Vanguard Group Inc. now owns 9,818,071 shares of the company’s stock worth $110,453,000 after purchasing an additional 166,837 shares during the period. Simplify Asset Management Inc. bought a new stake in shares of Alignment Healthcare in the 4th quarter worth approximately $1,494,000. KLP Kapitalforvaltning AS acquired a new stake in Alignment Healthcare in the fourth quarter worth $194,000. Finally, Sei Investments Co. acquired a new position in shares of Alignment Healthcare during the fourth quarter worth approximately $944,000. Institutional investors own 86.19% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on ALHC shares. JPMorgan Chase & Co. lifted their target price on Alignment Healthcare from $14.00 to $17.00 and gave the stock a “neutral” rating in a report on Thursday, March 6th. Stifel Nicolaus upped their price objective on shares of Alignment Healthcare from $18.00 to $23.00 and gave the company a “buy” rating in a research note on Tuesday. Bank of America lifted their target price on shares of Alignment Healthcare from $15.50 to $18.50 and gave the stock a “buy” rating in a research report on Tuesday, March 4th. Piper Sandler upped their price target on shares of Alignment Healthcare from $14.00 to $21.00 and gave the company an “overweight” rating in a research report on Tuesday, March 4th. Finally, Barclays lifted their price objective on shares of Alignment Healthcare from $8.00 to $9.00 and gave the stock an “underweight” rating in a research report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $15.39.

View Our Latest Research Report on ALHC

Insider Activity at Alignment Healthcare

In related news, CFO Robert Thomas Freeman sold 250,000 shares of the business’s stock in a transaction that occurred on Tuesday, March 4th. The stock was sold at an average price of $15.58, for a total value of $3,895,000.00. Following the completion of the sale, the chief financial officer now directly owns 1,635,849 shares in the company, valued at approximately $25,486,527.42. The trade was a 13.26 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO John E. Kao sold 90,000 shares of Alignment Healthcare stock in a transaction that occurred on Monday, January 13th. The shares were sold at an average price of $13.06, for a total transaction of $1,175,400.00. Following the completion of the transaction, the chief executive officer now directly owns 2,273,100 shares in the company, valued at approximately $29,686,686. This represents a 3.81 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 1,981,855 shares of company stock valued at $30,590,612. 6.60% of the stock is currently owned by corporate insiders.

Alignment Healthcare Stock Up 6.7 %

ALHC opened at $19.78 on Friday. The company has a market capitalization of $3.79 billion, a PE ratio of -25.69 and a beta of 1.32. The business has a 50-day moving average of $16.05 and a 200-day moving average of $13.53. Alignment Healthcare, Inc. has a fifty-two week low of $4.66 and a fifty-two week high of $21.06. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.60 and a quick ratio of 1.60.

Alignment Healthcare Profile

(Free Report)

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

Recommended Stories

Want to see what other hedge funds are holding ALHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alignment Healthcare, Inc. (NASDAQ:ALHCFree Report).

Institutional Ownership by Quarter for Alignment Healthcare (NASDAQ:ALHC)

Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.